Article Versions Notes

Zhou X, Flüchter P, Nickel K, Meckel K, Messerschmidt J, Böckle D, Knorz S, Steinhardt MJ, Krummenast F, Danhof S, et al. Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease. Cancers. 2020; 12(4):1035. https://doi.org/10.3390/cancers12041035

Zhou, Xiang, Patricia Flüchter, Katharina Nickel, Katharina Meckel, Janin Messerschmidt, David Böckle, Sebastian Knorz, Maximilian Johannes Steinhardt, Franziska Krummenast, Sophia Danhof, and et al. 2020. "Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease" Cancers 12, no. 4: 1035. https://doi.org/10.3390/cancers12041035

Zhou, X., Flüchter, P., Nickel, K., Meckel, K., Messerschmidt, J., Böckle, D., Knorz, S., Steinhardt, M. J., Krummenast, F., Danhof, S., Einsele, H., Kortüm, K. M., & Rasche, L. (2020). Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease. Cancers, 12(4), 1035. https://doi.org/10.3390/cancers12041035